{"disease":{"id":"pulmonary-lymphangiectasia","name":"pulmonary lymphangiectasia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02156115","title":"Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders","phase":"","overall_status":"TERMINATED","enrollment_count":14,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}